Lars Linderoth;Thomas Kruse;Jesper F. Lau;Henning Thoegersen
发明人:
Jesper F. Lau,Thomas Kruse,Lars Linderoth,Henning Thoegersen
申请号：
US13637522
公开号：
US20130143798A1
申请日:
2011.03.28
申请国别(地区):
US
年份:
2013
代理人:
摘要：
The present invention relates to novel peptide compounds which have an improved physical stability in solution and improved solubility at neutral pH, to the use of the compounds in therapy, to methods of treatment comprising administration of the compounds to patients in need thereof, and to the use of the compounds in the manufacture of medicaments. The compounds of the invention are of particular interest in relation to the treatment of hyperglycemia, diabetes and obesity, as well as a variety of diseases or conditions associated with hyperglycemia, diabetes and obesity.
